Anna Tocheva, PhD
img_Anna Tocheva
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
ASSISTANT PROFESSOR | Immunology & Immunotherapy
Research Topics
Bioinformatics, Cancer, Cellular Immunity, Genomics, Immunological Tolerance, Immunology, Personalized Medicine, Phosphorylation, Protein Kinases, Proteomics, Receptors, Signal Transduction, T Cells, Translational Research
Multi-Disciplinary Training Area
Genetics and Genomic Sciences [GGS], Immunology [IMM]
Publications

Selected Publications

Erratum: Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (Cell Reports Medicine (2024) 5(12), (S2666379124006232), (10.1016/j.xcrm.2024.101852)). Subhamoy Chakraborty, Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar, Avisek Banerjee, Hilal Ozakinci, Yazhini Mahendravarman, Konrad Snioch, Elisa de Stanchina, Misty D. Shields, Lewis E. Tomalin, Deniz Demircioglu, Theresa A. Boyle, Anna Tocheva, Dan Hasson, Triparna Sen. Cell Reports Medicine

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer. Subhamoy Chakraborty, Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar, Avisek Banerjee, Hilal Ozakinci, Yazhini Mahendravarman, Konrad Snioch, Elisa de Stanchina, Misty D. Shields, Lewis E. Tomalin, Deniz Demircioglu, Theresa A. Boyle, Anna Tocheva, Dan Hasson, Triparna Sen. Cell Reports Medicine

Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma. Bruno Giotti, Komal Dolasia, William Zhao, Peiwen Cai, Robert Sweeney, Elliot Merritt, Evgeny Kiner, Grace S. Kim, Atharva Bhagwat, Thinh Nguyen, Samarth Hegde, Bailey G. Fitzgerald, Sanjana Shroff, Travis Dawson, Monica Garcia-Barros, Jamshid Abdul-Ghafar, Rachel Chen, Sacha Gnjatic, Alan Soto, Rachel Brody, Seunghee Kim-Schulze, Zhihong Chen, Kristin G. Beaumont, Miriam Merad, Raja M. Flores, Robert P. Sebra, Amir Horowitz, Thomas U. Marron, Anna Tocheva, Andrea Wolf, Alexander M. Tsankov. Cancer Discovery

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Tocheva has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.